{"id":38393,"date":"2026-04-14T10:10:21","date_gmt":"2026-04-14T08:10:21","guid":{"rendered":"https:\/\/ggba.swiss\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/"},"modified":"2026-04-14T10:13:50","modified_gmt":"2026-04-14T08:13:50","slug":"deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/","title":{"rendered":"dEEGtal renforce sa gouvernance et acc\u00e9l\u00e8re sa validation clinique sur trois continents"},"content":{"rendered":"\n

La soci\u00e9t\u00e9 genevoise dEEGtal<\/a>, qui d\u00e9veloppe des logiciels propuls\u00e9s par l’IA pour am\u00e9liorer la prise en charge en neurologie et en psychiatrie, a nomm\u00e9 Ann Bunnenberg en tant que membre ind\u00e9pendante de son conseil d’administration. Entrepreneuse dans le domaine des dispositifs m\u00e9dicaux, investisseuse en capital-risque et avocate disposant d’une solide exp\u00e9rience dans le secteur des neurotechnologies, Bunnenberg apporte une expertise en d\u00e9veloppement de produits, en commercialisation internationale et en partenariats strat\u00e9giques \u00e0 un moment charni\u00e8re du d\u00e9veloppement de la soci\u00e9t\u00e9.<\/p>\n\n\n\n

Cette nomination co\u00efncide avec une p\u00e9riode de forte dynamique clinique. dEEGtal a valid\u00e9 son logiciel sur des donn\u00e9es collect\u00e9es dans sept centres d’\u00e9pilepsie en Europe et aux \u00c9tats-Unis dans le cadre d’un projet de recherche acad\u00e9mique ant\u00e9rieur \u00e0 sa cr\u00e9ation, accumulant des donn\u00e9es probantes pr\u00e9cliniques sur environ 2’000 patients. La soci\u00e9t\u00e9 a depuis \u00e9tabli trois collaborations cliniques actives : une \u00e9tude dans une unit\u00e9 de premi\u00e8re crise \u00e0 B\u00e2le \u00e9valuant la plateforme dans un contexte clinique r\u00e9el ; une \u00e9tude en cours \u00e0 l’h\u00f4pital Vall d’Hebron \u00e0 Barcelone ciblant environ 350 patients dans un contexte de service d’urgence ; et un partenariat avec l’UTMB \u00e0 Galveston, au Texas, depuis lequel ses essais cliniques am\u00e9ricains seront men\u00e9s.<\/p>\n\n\n\n

La plateforme combine de larges ensembles de donn\u00e9es EEG collect\u00e9s dans des centres cliniques europ\u00e9ens et am\u00e9ricains de premier plan avec des mod\u00e8les d’IA avanc\u00e9s, ciblant une identification plus rapide et plus pr\u00e9cise des patients \u00e0 risque d’\u00e9pilepsie apr\u00e8s une premi\u00e8re crise, un moment d\u00e9cisionnel critique o\u00f9 les outils diagnostiques actuels pr\u00e9sentent fr\u00e9quemment des lacunes. La soci\u00e9t\u00e9 a lev\u00e9 plus de CHF 1 million en financement seed en d\u00e9cembre 2024, ancr\u00e9 par une contribution de CHF 750’000 du Wyss Center<\/a> \u00e0 Gen\u00e8ve.<\/p>\n\n\n\n

Un tour de seed de CHF 4\u20135 millions est actuellement ouvert et devrait se cl\u00f4turer au deuxi\u00e8me trimestre 2026, finan\u00e7ant les essais cliniques am\u00e9ricains et positionnant dEEGtal comme une soci\u00e9t\u00e9 au stade commercial sur ce march\u00e9. Au-del\u00e0 de l’\u00e9pilepsie, la soci\u00e9t\u00e9 pr\u00e9voit d’\u00e9tendre son grand mod\u00e8le de signaux c\u00e9r\u00e9braux \u00e0 d’autres pathologies neurologiques et psychiatriques.<\/p>\n","protected":false},"excerpt":{"rendered":"

dEEGtal a nomm\u00e9 Ann Bunnenberg, entrepreneuse et investisseuse dans le secteur des neurotechnologies, au sein de son conseil d’administration, alors que la plateforme de signaux c\u00e9r\u00e9braux propuls\u00e9e par l’IA fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d’un tour de seed de CHF 4\u20135 millions.<\/p>\n","protected":false},"author":6,"featured_media":38390,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1180,1148,1181,1163,1141],"class_list":["post-38393","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"\ndEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa<\/title>\n<meta name=\"description\" content=\"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"dEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa\" \/>\n<meta property=\"og:description\" content=\"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-14T08:10:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T08:13:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"dEEGtal renforce sa gouvernance et acc\u00e9l\u00e8re sa validation clinique sur trois continents\",\"datePublished\":\"2026-04-14T08:10:21+00:00\",\"dateModified\":\"2026-04-14T08:13:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\"},\"wordCount\":395,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\",\"name\":\"dEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"datePublished\":\"2026-04-14T08:10:21+00:00\",\"dateModified\":\"2026-04-14T08:13:50+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"La plateforme IA de dEEGtal combine de larges ensembles de donn\u00e9es EEG avec des donn\u00e9es cliniques pour am\u00e9liorer les capacit\u00e9s diagnostiques et pr\u00e9dictives en neurologie et en psychiatrie, en commen\u00e7ant par la prise en charge de l'\u00e9pilepsie apr\u00e8s une premi\u00e8re crise. | \u00a9 dEEGtal\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"dEEGtal renforce sa gouvernance et acc\u00e9l\u00e8re sa validation clinique sur trois continents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"dEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa","description":"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/","og_locale":"fr_FR","og_type":"article","og_title":"dEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa","og_description":"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.","og_url":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-04-14T08:10:21+00:00","article_modified_time":"2026-04-14T08:13:50+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"dEEGtal renforce sa gouvernance et acc\u00e9l\u00e8re sa validation clinique sur trois continents","datePublished":"2026-04-14T08:10:21+00:00","dateModified":"2026-04-14T08:13:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/"},"wordCount":395,"image":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","keywords":["Artificial Intelligence","Digital Health","Financing","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/","url":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/","name":"dEEGtal cc\u00e9l\u00e8re sa validation clinique sur trois continents | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","datePublished":"2026-04-14T08:10:21+00:00","dateModified":"2026-04-14T08:13:50+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"dEEGtal a fait progresser ses \u00e9tudes cliniques en Suisse, en Espagne et aux \u00c9tats-Unis, en amont d'un tour de seed de CHF 4\u20135 millions.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","width":1180,"height":811,"caption":"La plateforme IA de dEEGtal combine de larges ensembles de donn\u00e9es EEG avec des donn\u00e9es cliniques pour am\u00e9liorer les capacit\u00e9s diagnostiques et pr\u00e9dictives en neurologie et en psychiatrie, en commen\u00e7ant par la prise en charge de l'\u00e9pilepsie apr\u00e8s une premi\u00e8re crise. | \u00a9 dEEGtal"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/deegtal-renforce-sa-gouvernance-et-accelere-sa-validation-clinique-sur-trois-continents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"dEEGtal renforce sa gouvernance et acc\u00e9l\u00e8re sa validation clinique sur trois continents"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=38393"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38393\/revisions"}],"predecessor-version":[{"id":38395,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38393\/revisions\/38395"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/38390"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=38393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=38393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=38393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}